Sumitomo Pharma Co., Ltd. (DNPUF)
8.405
0.00 (0.00%)
USD |
OTCM |
Aug 24, 16:00
Sumitomo Pharma Debt to Equity Ratio : 0.3932 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.3932 |
| March 31, 2026 | 0.7666 |
| December 31, 2025 | 0.8962 |
| September 30, 2025 | 0.9897 |
| June 30, 2025 | 1.755 |
| March 31, 2025 | 1.854 |
| December 31, 2024 | 2.254 |
| September 30, 2024 | 3.410 |
| June 30, 2024 | 2.425 |
| March 31, 2024 | 2.742 |
| December 31, 2023 | 1.199 |
| September 30, 2023 | 0.9315 |
| June 30, 2023 | 0.8916 |
| March 31, 2023 | 0.8516 |
| December 31, 2022 | 0.3932 |
| September 30, 2022 | 0.3865 |
| June 30, 2022 | 0.3996 |
| March 31, 2022 | 0.4681 |
| December 31, 2021 | 0.449 |
| September 30, 2021 | 0.4644 |
| June 30, 2021 | 0.4758 |
| March 31, 2021 | 0.5007 |
| December 31, 2020 | 0.5383 |
| September 30, 2020 | 0.5473 |
| June 30, 2020 | 0.5494 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.5918 |
| December 31, 2019 | 0.5837 |
| September 30, 2019 | 0.0576 |
| June 30, 2019 | 0.0617 |
| March 31, 2019 | 0.0662 |
| December 31, 2018 | 0.0636 |
| September 30, 2018 | 0.066 |
| June 30, 2018 | 0.0997 |
| December 31, 2017 | 0.1148 |
| September 30, 2017 | 0.121 |
| June 30, 2017 | 0.144 |
| March 31, 2017 | 0.1613 |
| December 31, 2016 | 0.1435 |
| September 30, 2016 | 0.0669 |
| June 30, 2016 | 0.1196 |
| March 31, 2016 | 0.1277 |
| December 31, 2015 | 0.174 |
| September 30, 2015 | 0.1797 |
| June 30, 2015 | 0.1826 |
| March 31, 2015 | 0.2046 |
| December 31, 2014 | 0.1977 |
| September 30, 2014 | 0.215 |
| June 30, 2014 | 0.2342 |
| March 31, 2014 | 0.2514 |
| December 31, 2013 | 0.2669 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 0.6536 |
| Daiichi Sankyo Co., Ltd. | 0.2939 |
| Eisai Co., Ltd. | 0.2993 |
| Chugai Pharmaceutical Co., Ltd. | 0.0087 |
| Santen Pharmaceutical Co., Ltd. | 0.1033 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 5.198B |
| Total Liabilities (Quarterly) | 2.685B |
| Shareholders Equity (Quarterly) | 2.514B |
| Current Ratio | 1.212 |
| Net Debt Paydown Yield | 5.27% |